IL74586A - Dopamine beta-hydroxylase inhibiting phenylalkylimidazole derivatives - Google Patents

Dopamine beta-hydroxylase inhibiting phenylalkylimidazole derivatives

Info

Publication number
IL74586A
IL74586A IL74586A IL7458685A IL74586A IL 74586 A IL74586 A IL 74586A IL 74586 A IL74586 A IL 74586A IL 7458685 A IL7458685 A IL 7458685A IL 74586 A IL74586 A IL 74586A
Authority
IL
Israel
Prior art keywords
phenylalkylimidazole
derivatives
dopamine beta
hydroxylase inhibiting
hydroxylase
Prior art date
Application number
IL74586A
Other languages
English (en)
Other versions
IL74586A0 (en
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Priority to IL8630385A priority Critical patent/IL86303A/xx
Publication of IL74586A0 publication Critical patent/IL74586A0/xx
Priority to IL86303A priority patent/IL86303A0/xx
Publication of IL74586A publication Critical patent/IL74586A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL74586A 1984-03-19 1985-03-13 Dopamine beta-hydroxylase inhibiting phenylalkylimidazole derivatives IL74586A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL8630385A IL86303A (en) 1984-03-19 1985-03-13 3-(3',5'-dihalophenyl)propanamine n-acetaldehydes and their preparation
IL86303A IL86303A0 (en) 1984-03-19 1988-05-06 3-(3',5'-dihalophenyl)propanamine n-acetaldehydes and their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59066584A 1984-03-19 1984-03-19

Publications (2)

Publication Number Publication Date
IL74586A0 IL74586A0 (en) 1985-06-30
IL74586A true IL74586A (en) 1988-11-30

Family

ID=24363168

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74586A IL74586A (en) 1984-03-19 1985-03-13 Dopamine beta-hydroxylase inhibiting phenylalkylimidazole derivatives

Country Status (9)

Country Link
KR (1) KR850006189A (fi)
DK (2) DK118985A (fi)
FI (1) FI83309C (fi)
HU (1) HU194184B (fi)
IL (1) IL74586A (fi)
NO (1) NO162616C (fi)
NZ (2) NZ211440A (fi)
PH (1) PH21032A (fi)
ZW (1) ZW4285A1 (fi)

Also Published As

Publication number Publication date
FI851073L (fi) 1985-09-20
NO162616C (no) 1990-01-24
FI83309C (fi) 1991-06-25
HU194184B (en) 1988-01-28
DK118985D0 (da) 1985-03-15
ZW4285A1 (en) 1985-06-26
NZ211440A (en) 1988-09-29
DK118985A (da) 1985-09-20
HUT37602A (en) 1986-01-23
NZ222876A (en) 1988-09-29
NO851056L (no) 1985-09-20
NO162616B (no) 1989-10-16
DK189691D0 (da) 1991-11-20
IL74586A0 (en) 1985-06-30
KR850006189A (ko) 1985-10-02
DK189691A (da) 1991-11-20
FI83309B (fi) 1991-03-15
FI851073A0 (fi) 1985-03-18
PH21032A (en) 1987-06-30

Similar Documents

Publication Publication Date Title
GB2153355B (en) Fungicidal azolyl-cycloalkanol derivatives
GB2208647B (en) Methyl 3-hydroxy-2-phenylphosphenate derivatives
GB2163150B (en) 3-aminopropoxyaryl derivatives
GB8520924D0 (en) Heterocyclic derivatives
GB2152033B (en) Sulfonamido-benzamide derivatives
EP0163324A3 (en) Aminoalkylphenoxy derivatives
GB2155925B (en) Pyrimidylpiperazine derivatives
GB2164644B (en) Benzonorbornene derivatives
DE3565267D1 (en) 9a-aza-9a-homoerythromycin derivatives
EP0318682A3 (en) Tricyclic thiazole derivatives
GB2159814B (en) Iminothiazolidine derivatives
GB8401149D0 (en) Furanone derivatives
GB2165845B (en) Dioxinopyridine derivatives
IL74586A (en) Dopamine beta-hydroxylase inhibiting phenylalkylimidazole derivatives
GB2162178B (en) 4-cyano-3-oxo-hexahydro-isoquinoline derivatives
GB2165247B (en) Azabicycloheptene derivatives
EP0174271A3 (en) Anthraceme derivatives
GB2158066B (en) Apovincaminol derivatives
ZA858408B (en) Substituted azolylmethyl-cyclopropyl-carbinol derivatives
GB2169290B (en) Pyrone -3- carboxamide derivatives
GB8416720D0 (en) Thiazolidine derivatives
GB8401010D0 (en) Thioketene derivatives
ZA883493B (en) Dopamine derivatives
IE881601L (en) Dopamine beta-hydroxylase inhibitors.
GB2165243B (en) 17-sulphonamido yohimbane derivatives